Annual Accounts Receivable
$12.10 M
+$12.10 M+100.00%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual accounts receivable is $12.10 million, with the most recent change of +$12.10 million (+100.00%) on December 31, 2023.
- AVDL annual accounts receivable is now -32.15% below its all-time high of $17.84 million, reached on December 31, 2016.
Performance
AVDL Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$37.10 M
+$3.73 M+11.16%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly accounts receivable is $37.10 million, with the most recent change of +$3.73 million (+11.16%) on September 30, 2024.
- Over the past year, AVDL quarterly accounts receivable has increased by +$25.00 million (+206.55%).
- AVDL quarterly accounts receivable is now at all-time high.
Performance
AVDL Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AVDL Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | +206.6% |
| 3 y3 years | - | +1990.3% |
| 5 y5 years | +6.8% | +1990.3% |
AVDL Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | -32.1% | -100.0% | at high | -100.0% |
Avadel Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $37.10 M(+11.2%) |
| Jun 2024 | - | $33.38 M(+47.1%) |
| Mar 2024 | - | $22.69 M(+87.5%) |
| Dec 2023 | $12.10 M(>+9900.0%) | $12.10 M(+94.0%) |
| Sep 2023 | - | $6.24 M(+251.5%) |
| Jun 2023 | - | $1.77 M(>+9900.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(-100.0%) |
| Jun 2020 | - | $5.69 M(-35.3%) |
| Mar 2020 | - | $8.80 M(+6.2%) |
| Dec 2019 | $8.28 M(-26.9%) | $8.28 M(-5.1%) |
| Sep 2019 | - | $8.72 M(-14.2%) |
| Jun 2019 | - | $10.17 M(-13.6%) |
| Mar 2019 | - | $11.77 M(+3.9%) |
| Dec 2018 | $11.33 M(-23.4%) | $11.33 M(+16.5%) |
| Sep 2018 | - | $9.72 M(-34.9%) |
| Jun 2018 | - | $14.94 M(-10.4%) |
| Mar 2018 | - | $16.68 M(+12.8%) |
| Dec 2017 | $14.79 M(-17.1%) | $14.79 M(-38.6%) |
| Sep 2017 | - | $24.08 M(+24.9%) |
| Jun 2017 | - | $19.29 M(+43.2%) |
| Mar 2017 | - | $13.46 M(-24.5%) |
| Dec 2016 | $17.84 M(+138.3%) | $17.84 M(+15.9%) |
| Sep 2016 | - | $15.39 M(+62.3%) |
| Jun 2016 | - | $9.49 M(+95.0%) |
| Mar 2016 | - | $4.87 M(-35.0%) |
| Dec 2015 | $7.49 M(+345.9%) | $7.49 M(+114.0%) |
| Jun 2015 | - | $3.50 M(>+9900.0%) |
| Mar 2015 | - | $0.00(-100.0%) |
| Dec 2014 | $1.68 M(-72.9%) | $1.68 M(-43.8%) |
| Sep 2014 | - | $2.99 M(-17.8%) |
| Jun 2014 | - | $3.64 M(-10.0%) |
| Mar 2014 | - | $4.04 M(-34.9%) |
| Dec 2013 | $6.20 M(+13.5%) | $6.20 M(-1.9%) |
| Sep 2013 | - | $6.33 M(+25.6%) |
| Jun 2013 | - | $5.04 M(-4.0%) |
| Mar 2013 | - | $5.25 M(-3.9%) |
| Dec 2012 | $5.46 M(-29.6%) | $5.46 M(-1.9%) |
| Jun 2012 | - | $5.57 M(-0.2%) |
| Mar 2012 | - | $5.58 M(-28.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $7.76 M(+3.8%) | $7.76 M(+25.2%) |
| Sep 2011 | - | $6.20 M(+7.1%) |
| Jun 2011 | - | $5.79 M(-21.8%) |
| Mar 2011 | - | $7.40 M(-1.1%) |
| Dec 2010 | $7.48 M(-13.8%) | $7.48 M(-26.9%) |
| Sep 2010 | - | $10.23 M(+65.3%) |
| Jun 2010 | - | $6.19 M(-14.3%) |
| Mar 2010 | - | $7.22 M(-16.8%) |
| Dec 2009 | $8.68 M(+24.3%) | $8.68 M(+18.2%) |
| Sep 2009 | - | $7.34 M(-15.5%) |
| Jun 2009 | - | $8.69 M(-14.2%) |
| Mar 2009 | - | $10.13 M(+45.1%) |
| Dec 2008 | $6.98 M(+39.9%) | $6.98 M(-2.1%) |
| Sep 2008 | - | $7.13 M(+16.2%) |
| Jun 2008 | - | $6.14 M(-4.3%) |
| Mar 2008 | - | $6.41 M(+28.5%) |
| Dec 2007 | $4.99 M(-10.7%) | $4.99 M(-35.8%) |
| Sep 2007 | - | $7.76 M(+12.2%) |
| Jun 2007 | - | $6.92 M(+17.8%) |
| Mar 2007 | - | $5.88 M(+5.2%) |
| Dec 2006 | $5.58 M(+116.1%) | $5.58 M(-22.2%) |
| Sep 2006 | - | $7.18 M(+21.1%) |
| Jun 2006 | - | $5.93 M(+84.8%) |
| Mar 2006 | - | $3.21 M(+24.2%) |
| Dec 2005 | $2.58 M(-68.5%) | $2.58 M(-58.6%) |
| Sep 2005 | - | $6.24 M(-14.0%) |
| Jun 2005 | - | $7.25 M(-14.2%) |
| Mar 2005 | - | $8.46 M(+3.1%) |
| Dec 2004 | $8.20 M(-2.0%) | $8.20 M(+57.4%) |
| Sep 2004 | - | $5.21 M(0.0%) |
| Jun 2004 | - | $5.21 M(-32.8%) |
| Mar 2004 | - | $7.75 M(-7.3%) |
| Dec 2003 | $8.37 M(+141.7%) | $8.37 M(+92.5%) |
| Sep 2003 | - | $4.35 M(-27.6%) |
| Jun 2003 | - | $6.01 M(+71.5%) |
| Mar 2003 | - | $3.50 M(+1.2%) |
| Dec 2002 | $3.46 M(-54.4%) | $3.46 M(+17.8%) |
| Sep 2002 | - | $2.94 M(-61.3%) |
| Dec 2001 | $7.60 M(+187.6%) | $7.60 M(+187.6%) |
| Dec 2000 | $2.64 M | $2.64 M |
FAQ
- What is Avadel Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual accounts receivable year-on-year change?
- What is Avadel Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Avadel Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of AVDL is $12.10 M
What is the all time high annual accounts receivable for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual accounts receivable is $17.84 M
What is Avadel Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, AVDL annual accounts receivable has changed by +$12.10 M (+100.00%)
What is Avadel Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of AVDL is $37.10 M
What is the all time high quarterly accounts receivable for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly accounts receivable is $37.10 M
What is Avadel Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, AVDL quarterly accounts receivable has changed by +$25.00 M (+206.55%)